BRIEF-Valeant considering disposal of Obagi Medical Products as well as Provenge - Bloomberg

Tue May 17, 2016 4:25pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 17 (Reuters) -

* Valeant Pharmaceuticals considering disposal Of Obagi Medical Products Inc, dermatology company it acquired in 2013, as well as Provenge - Bloomberg

* Valeant Pharmaceuticals may sell drugs acquired from Marathon Pharmaceuticals last year - Bloomberg citing source

* Valeant Pharmaceuticals divestitures could raise as much as $1 billion and attract other drugmakers with an interest in those areas - Bloomberg Source: (bloom.bg/1WBHJIN) Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)